Back
Pliant Therapeutics Vs. Keros Therapeutics Industry Stock Comparison
Sell
34
PLRX
Pliant Therapeutics
Last Price:
$1.35
Seasonality Move:
53.22%
Sell
31
KROS
Keros Therapeutics
Last Price:
$14.33
Seasonality Move:
-5.28%
Sell
34
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy, Sell or Hold?
-
The current Pliant Therapeutics [PLRX] share price is $1.35. The Score for PLRX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
PLRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
-
The current Keros Therapeutics [KROS] share price is $14.64. The Score for KROS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
KROS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PLRX Stock Price Chart
What is Pliant Therapeutics's stock price today?
-
The Pliant Therapeutics share price today is $1.35Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $14.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight buying pressure.
PLRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 42.02 | Sell |
| Chaikin Money Flow: | 504739 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.33 - 1.55) | Sell |
| Bollinger Bands (100): | (-0.07 - 8.91) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 63.59 | Buy |
| Chaikin Money Flow: | 2919 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.82 - 14.5) | Buy |
| Bollinger Bands (100): | (10.58 - 13.96) | Buy |
PLRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.34 | Buy |
| 20-day SMA: | 1.42 | Sell |
| 50-day SMA: | 1.44 | Sell |
| 200-day SMA: | 8.82 | Sell |
| 8-day EMA: | 1.34 | Buy |
| 20-day EMA: | 1.4 | Sell |
| 50-day EMA: | 2.07 | Sell |
| 200-day EMA: | 7.26 | Sell |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.26 | Buy |
| 20-day SMA: | 14.11 | Buy |
| 50-day SMA: | 12.82 | Buy |
| 200-day SMA: | 31.91 | Sell |
| 8-day EMA: | 14.29 | Buy |
| 20-day EMA: | 14.01 | Buy |
| 50-day EMA: | 13.79 | Buy |
| 200-day EMA: | 26.22 | Sell |
Pliant Therapeutics Earnings Growth & PLRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.50 per share, a decrease next quarter of $0.13 per share, an increase this year of $1.09 per share, and an increase next year of $0.08 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.02 per share, an increase this year of $4.32 per share, and a decrease next year of $4.46 per share.
Pliant Therapeutics Technical Analysis
| May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||